EVALUATION OF 5-YEAR SURVIVAL OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH STAGE III NON-SMALL CELL LUNG CANCER TREATED WITH CONCURRENT CHEMORADIOTHERAPY AT NGHE AN ONCOLOGY HOSPITAL. YHCĐ 2026, 67 (Số CĐ12- Bệnh viện Ung bướu Nghệ An). https://doi.org/10.52163/yhc.v67iCD12.6134.